Signaling pathways in rheumatoid arthritis: implications for targeted therapy
Сигнальные пути при ревматоидном артрите: значение для таргетной терапии
2023-02-17
SCID: 54.1/j3zhhmbm
Discuss with AI
Molecular mechanismsRheumatoid arthritisSignaling pathwaysTargeted therapyTherapeutic inhibitors
Figures from the paper
Abstract (AI)
Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease progression leads to joint deformity and associated loss of function, which significantly impacts the quality of life for sufferers and adds to losses in the labor force. In the past few decades, RA has attracted increased attention from researchers, the abnormal signaling pathways in RA are a very important research field in the diagnosis and treatment of RA, which provides important evidence for understanding this complex disease and developing novel RA-linked intervention targets. The current review intends to provide a comprehensive overview of RA, including a general introduction to the disease, historical events, epidemiology, risk factors, and pathological process, highlight the primary research progress of the disease and various signaling pathways and molecular mechanisms, including genetic factors, epigenetic factors, summarize the most recent developments in identifying novel signaling pathways in RA and new inhibitors for treating RA. therapeutic interventions including approved drugs, clinical drugs, pre-clinical drugs, and cutting-edge therapeutic technologies. These developments will hopefully drive progress in new strategically targeted therapies and hope to provide novel ideas for RA treatment options in the future.
Key Findings
1
Abnormal signaling pathways are central to RA diagnosis and treatment research because they help clarify disease mechanisms and identify therapeutic targets.
2
RA interventions span approved, clinical-stage, preclinical, and emerging targeted technologies, supporting development of more strategically targeted treatments.
3
Recent research has identified novel RA-associated signaling pathways and inhibitors with potential therapeutic value.
4
Rheumatoid arthritis is an incurable systemic autoimmune disease whose progression causes joint deformity, functional loss, reduced quality of life, and workforce losses.
5
The review synthesizes genetic, epigenetic, molecular, and signaling-pathway mechanisms contributing to RA pathogenesis.
Research Object
rheumatoid arthritis
Research Subject
abnormal signaling pathways and molecular mechanisms underlying rheumatoid arthritis, including therapeutic targeting and pathway inhibition
Publication Details
Publication Date
2023-02-17
Journal
Publisher
ISSN
Cited by
605
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Cited by3
The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials2025
The Identification of Novel Therapeutic Biomarkers in Rheumatoid Arthritis: A Combined Bioinformatics and Integrated Multi-Omics Approach2025
Chondrocyte inflammatory-immune responses in osteoarthritis: From pathogenesis to therapeutic intervention2026